Secondary Investor Saints Capital Offers VCs A Third Way Out
This article was originally published in Start Up
Executive Summary
Secondary firms such as Saints, which is raising a $300 million seventh fund, step in to acquire stakes from other VCs at the end of their funds’ lifespans. With a biotech VC shakeout in progress, the secondaries are banking on more opportunities soon.